References
- Berrón S, De la Fuente L, Martín E, Vázquez A. Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup C. Eur J Clin Microbiol Infect Dis 1998; 17: 85–9.
- Berrón S, Sáez-Nieto JA, Vázquez JA. Aplicación de marcadores epidemiolói gicos en cepas de Neisseria meningitidis con sensibilidad disminuida a penicilina aisladas en España (1985–1990). Rev Esp Quim 5; 1992: 35–41.
- Berrón S, Vázquez JA. Increase in moderate penicillin resistance and serogroup C in meningococcal strains isolated in Spain. Is there any relationship? Clin Infect Dis 1994; 18: 161–5.
- Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, et al. The changing epidemiology of meningococcal disease in the United States, 1992–1996. J Infect Dis 180; 1999: 1894–901.
- Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, et al. Meningococcal disease in a large urban population (Barcelona, 1987–1992). Arch Intern Med 159; 1999: 2329–40.
- Meningoccoccal Disease Surveillance Group. Meningococcal disease: secondary attack rate and chemoprophylaxis in the United States, 1974. JAMA 1976; 235: 261–5.
- Knapp JS, Rice RJ. Neisseria and Branhamella. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 6th ed. Washington D.C.: American Society for Microbiology Press, 1995: 324–40.
- Vedros NA. Serology of meningococcus. In: Bergan T, Norris JR, eds. Methods in microbiology, Vol. 10. New York: Academic Press, 1978: 293–314.
- Direccióin General de Salud Pública. Plan de Prevencion Integral de la Meningitis en la Comunidad Valenciana. Valencia, Spain: Conselleria de Sanitat, Generalitat Valenciana, 1999: 39–55.
- Schwentker FF, Gelman S, Long PH. The treatment of meningococcic meningitis with sulfanilamide: preliminary report. JAMA 1937; 108: 1407–8.
- Vázquez JA, Marcos C, Berrón S. Infección meningocócica. Sero/subtyping of Neisseria meningitidis isolated from patients in Spain. Epidemiol Infect 1994; 113: 267–74.
- Connolly M, Noah N. Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993–6. Epidemiol Infect 122; 1999: 41–9.
- Váizquez JA, De la Fuente L, Berrói n S. Infeccióin meningocóicica. Informe del laboratorio de referencia de meningococos (1995). Bol Epidemiol Semanal 4; 1995: 37–40.
- Rosenstein N, Levine O, Taylor JP, Evans D, Plikaytis BD, Wenger JD, et al. Efficacy of meningococcal vaccine and barriers to vaccination. JAMA 1998; 279: 435–9.
- Centers for Disease Control and Prevention. Control and prevention of meningococcal disease and control and prevention of serogroup C meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997; 46 (RR-5): 1–8.
- De Wals P, Dionne M, Douville-Fradet M, Boulinne N, Drapeau J, De Serres G. Impact of a mass immunization campaign against serogoup C meningococcus in the Province of Quebec, Canada. Bull World Health Organ 1996; 74: 407–11.
- Artenstein MS, Gold R, Zimmerly JG, Wyle FA, Schneider H, Harkins C. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med 1970; 282: 417–20.
- Gotschlich EC, Goldschneider I, Artenstein MS. Human immunity to the meningococcus. J Exp Med 1969; 129: 1385–95.
- Moore PS, Harrison LH, Telzak EE, Ajello GW, Broome CV. Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA 1988; 260: 2686–9.
- Blakesbrough IS, Greenwood BM, Whittle HC, Bradley AK. Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys. Ann Trop Med Parasitol 1983; 77: 175–8.
- Hassan-King MKA, Wall RA, Greenwood BM. Meningococcal carriage, meningococcal disease and vaccination. J Infect 1988; 16: 55–9.
- Racoosin JA, Whitney CG, Conover CS, Diaz PS. Serogroup Y meningococcal disease in Chicago, 1991–1997. JAMA 280; 1998: 2094–8.